Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,009 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

A Study of TTI-622 in Combination With Daratumumab Hyaluronidase-fihj in People With Multiple Myeloma

NCT05139225

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
View Trial Details
Completed

A Real-world Study in Participants With Smoldering Multiple Myeloma

NCT06472778

Conditions
Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • CHRU de Tours - Hopital Trousseau Chambray-lès-Tours, France
  • CHU Montpellier Montpellier, France
  • Centre Hospitalier Regional d'Orleans (CHRO) - Hopital La Source Orléans, France
  • Hopital Pitie Salpetriere Paris, France
View all 29 locations
View Trial Details
Completed

DZD8586 in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

NCT05824585

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • Research site New York, United States
  • Research site Albury, New South Wales, Australia
  • Research site Ballarat, Victoria, Australia
  • Research site Melbourne, Victoria, Australia
View Trial Details
Completed

ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies

NCT05653271

Conditions
B-cell Lymphoma, Burkitt Lymphoma, DLBCL, +23 more
Locations
  • AdventHealth Orlando Orlando, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • Indiana University Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
View all 13 locations
View Trial Details
Completed

Pharmacogenetic Study of Antimitotic Therapies Involved in Hepatic VOD in Children With Nephroblastoma or ALL

NCT04168788

Conditions
Acute Lymphoblastic Leukemia, Cardiovascular Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +30 more
Locations
  • Univesity Hostipal of Amiens Amiens, France
  • University Hospital of Bordeaux Bordeaux, France
  • University of Brest Brest, France
  • Centre Oscar Lambret Lille, France
View Trial Details

Related conditions